Of course, considering Neuren's situation / pipeline / results to date, the company will base a fair T/O price on a DCF valuation. Isn't that a no brainer?
Whether any other side would come to the party is another matter, especially if there is a huge discrepancy between DCF & SP - which would almost certainly be the case.
Of course, considering Neuren's situation / pipeline / results...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.26 |
Change
-0.220(1.42%) |
Mkt cap ! $1.947B | |||
| Open | High | Low | Value | Volume |
| $15.20 | $15.33 | $15.02 | $5.545M | 364.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 170 | $15.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.26 | 15 | 1 |
View Market Depth
| Last trade - 15.14pm 22/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |